Weight of accepted product used for take-back, reuse or disposal

Unit

i
: Metric tonnes (t)

Indicator

i
: Waste minimized, reused, composted or recycled

Metric type

i
: Response

Framework alignment notes

i
E5-5, 37c, E5-5, AR 28
306-2
HC-BP-250a.4
Refer to the PSCI's Decarbonization Playbook for the Pharmaceutical Industry for alignment to the metric
T16

Target example

[Company name] will increase the total weight of product accepted through take-back programs by [target amount, in absolute tonnes or percentage] by [target year], compared to a [baseline year] baseline

Target Source: WBCSD target template

Sector

i
Pharmaceutical

Value chain stage

i
Manufacturing End of Life

Metric assessment

i

Relevance: High

Feasibility: Low

Related actions

Reduce solid waste generated from the disposal of used pharmaceutical products through public education and information campaigns encouraging correct packaging and device disposal

Reduce solid waste generated from the disposal of used pharmaceutical products through public education and information campaigns encouraging correct packaging and device disposal

Description

Value chain stage

End of Life

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce APIs (including antibiotics) in the environment through public education and information campaigns encouraging correct medicine disposal

Reduce APIs (including antibiotics) in the environment through public education and information campaigns encouraging correct medicine disposal

Description

Value chain stage

End of Life

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Minimize waste from single-use packaging by redesigning products and systems to prioritize circularity

Minimize waste from single-use packaging by redesigning products and systems to prioritize circularity

Description

Value chain stage

End of Life

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Design processes and products to minimize waste and maximize circularity

Design processes and products to minimize waste and maximize circularity

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

E.g., expanding use of recycled or biodegradable materials, such as for medicine delivery devices.